Please login to create your UC TechAlerts.
Request a new password for
Omnidirectional MRI Catheter Resonator for Interventional Procedures
This invention describes an orientation-independent device that can create bright and highly localized signal enhancement during magnetic resonance imaging.
Mid-pregnancy Serum Biomarkers for Predicting Preterm Birth
This mid-pregnancy serum biomarker test can accurately and effectively identify pregnancies that will deliver before 32-weeks of gestation.
Novel Method Of Imaging Infection Using Radiotracers
UCSF researchers have invented novel radiotracers that allow imaging of both gram-positive and gram-negative bacteria infections using positron emission tomography (PET) to detect spread of infection and to distinguish that from other mimics.
Novel Method for Finding Low Abundance Sequences By Hybridization
This invention describes a novel method for enriching rare sequences in nucleic acid libraries.
Unique Method Of Predicting Response To Immunotherapy For Human Melanoma
This invention describes a technical advancement in human tissue digestion that allows for the successful profiling of tumor infiltrating lymphocytes (TILs) by flow cytometry. Using this digestion method, UCSF researchers were able to determine that patients with 30% or more TILs with high expression of biomarkers PD-1 and CTLA-4 are likely to respond to anti-PD-1 cancer immunotherapy.
Cell Aging Measured by Telomere Length and Telomerase Activity as a Diagnostic and Prognostic Biomarker of Major Depressive Disorder
This invention describes a new way to predict response to antidepressants in patients with Major Depressive Disorder (MDD) and the likelihood of developing the disease by measuring telomere length and telomerase activity.
System And Method For Rapid Automated Head Computed Tomography Analysis
This invention is a novel, automated method to rapidly detect and locate neurological emergencies such as acute intracranial hemorrhage on head computed tomography (CT) images using deep learning technology.
A Companion Diagnostic for Lung Cancer Patients with Tyrosine Kinase Inhibitor (TKI) Resistance
This invention contains methods of measuring AXL and GAS6 expression and/or activity in lung cancer tumors with tyrosine kinase treatment resistance.
A Blood-based Diagnostic Test for Early Stage Detection of Autism Spectrum Disorders (ASD)
A revolutionary blood-based diagnostic test measures three kinase signaling pathway activities to determine the likelihood of the patient having ASD at an early stage.
RAPID Non-invasive Diagnostic for Planktonic and Biofilm Fungal Infections
UCSF researchers have developed a non-invasive test for the rapid diagnosis of Candida albicans infections in both planktonic and biofilm form.
Molecular Diagnosis And Classification Of Malignant Melanoma
These novel sets of biomarkers predict the five year survival rate of melanoma patients.
A Novel Therapeutic Target and Diagnostic/Prognostic Marker for Lung Adenocarcinoma
This invention identifies a novel non-coding RNA (ncRNA) transcript as a potential diagnostic and prognostic marker for lung adenocarcinoma. Furthermore, inhibitors of this novel ncRNA might hold therapeutic potential.
Rapid Structure-guided Generation of Antibodies for Detecting Protein Phosphorylation Modifications
This invention is a rapid, robust method to generate high-quality, renewable antibodies specific to protein phosphorylations via antibody scaffolds.
NOVEL GLIOMA-SPECIFIC VACCINE FOR PEDIATRIC AND YOUNG-ADULT PATIENTS
UCSF researchers have developed a vaccine against pediatric gliomas by targeting a novel epitope.
A Gene Expression Panel For Diagnosis Of Ebola Virus Infection
This invention identifies a novel host gene expression panel to screen for the Ebola virus in pre-symptomatic patients.
Double Tuned Phase Array Coils for Simultaneous Proton and Heteronuclear MRI
UCSF researchers have developed a new double-tuned radiofrequency (RF) coil for simultaneous proton and heteronuclear magnetic resonance imaging (MRI). This novel coil design allows for independent frequency adjustments of the two magnetic resonance modes.
Rapid In Vivo Quantitative Imaging for Clinical Diagnosis of Blood Clot Formation
This advanced quantitative real-time in vivo imaging technology provides fast and highly specific non-invasive diagnosis of thrombotic diseases such as stoke and cancer.
Plasma Biomarkers for Monitoring Cancer Chemotherapy Efficacy
Highly sensitive protein biomarkers that can be used to monitor the extent of apoptosis in order to optimize chemotherapy regimen in cancer patients
Generation of Metagenomic Next-generation Sequencing Libraries Optimal for Long-read Sequencing Technologies
This invention is a technology that prepares physical long-read fragments from short-read metagenomic libraries that can be sequenced quickly and efficiently using long-read next-generation sequencing technologies. As of this time, there are no existing commercially available technologies that can offer this advantage.
Methods for Real-Time Sequencing Analysis of Infectious Diseases
A novel point-of-care technology enables real-time analysis and visualization of metagenomic sequence data for pathogen detection using a device that generates long sequencing reads at low cost and high speed with minimal sample preparation and instrumentation.
Novel Predictive Cancer Biomarker for PARP lnhibitors in Cancer Treatment
This novel biomarker predicts the treatment response of PARP inhibitors in cancer patients.
IMMUNOGENIC PEPTIDES OF AQP4 FOR THE DIAGNOSIS AND TREATMENT OF NEUROMYELITIS OPTICA (NMO)
This invention identifies the exact regions within AQP4 that trigger an immune response, which provide promising therapeutic potential for the diagnosis and treatment of Neuromyelitis Optica.
HIGHLY SPECIFIC DIAGNOSTIC CLASSIFIERS OF ENDOMETRIOSIS
This invention provides a non-invasive method to detect endometriosis in women through the use of novel diagnostic biomarkers that detect the presence, absence, and/or severity of endometriosis.
Methods And Reagents For Live Biopsy
This invention identifies a set of antibodies that allow direct imaging of immune cells in a tumor biospecimen.
Novel ELISA assay to detect SULF2 in patient samples
This ELISA technique detects Sulfatase2 (SULF2), an extracellular heparan sulfate-degrading enzyme that is overexpressed in many cancers. Furthermore, this technique can potentially serve as a diagnostic for cirrhosis.